Literature DB >> 30040536

Assessment of the NSQIP Surgical Risk Calculator in Predicting Microvascular Head and Neck Reconstruction Outcomes.

Yue Ma1, Benjamin M Laitman2, Vir Patel2, Marita Teng1, Eric Genden1, Samuel DeMaria3, Brett A Miles1.   

Abstract

OBJECTIVE: This study evaluated the accuracy of the Surgical Risk Calculator (SRC) of the ACS NSQIP (American College of Surgeons National Surgical Quality Improvement Program) in predicting head and neck microvascular reconstruction outcomes. STUDY
DESIGN: Retrospective analysis.
SETTING: Tertiary medical center. SUBJECTS AND METHODS: A total of 561 free flaps were included in the analysis. The SRC-predicted 30-day rates of postoperative complications, hospital length of stay (LOS), and rehabilitation discharge were compared with the actual rates and events. The SRC's predictive value was examined with Brier scores and receiver operating characteristic area under the curve.
RESULTS: A total of 425 myocutaneous, 134 osseous (84 fibula, 47 scapula, and 3 iliac crest), and 2 omental free flaps were included in this study. All perioperative complications evaluated had area under the curve values ≤0.75, ranging from 0.480 to 0.728. All but 2 postoperative complications had Brier scores >0.01. SRC-predicted LOS was 9.4 ± 2.38 days (mean ± SD), which did not strongly correlate with the actual LOS of 11.98 ± 9.30 days ( r = 0.174, P < .0001).
CONCLUSION: The SRC is a poor predictor for surgical outcome among patients undergoing microvascular head and neck reconstruction.

Entities:  

Keywords:  NSQIP; free flap; free tissue transfer; surgical risk calculator

Mesh:

Year:  2018        PMID: 30040536     DOI: 10.1177/0194599818789132

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  1 in total

1.  Optimizing classical risk scores to predict complications in head and neck surgery: a new approach.

Authors:  Ana Sousa Menezes; Antero Fernandes; Jéssica Rocha Rodrigues; Carla Salomé; Firmino Machado; Luís Antunes; Joaquim Castro Silva; Eurico Monteiro; Lúcio Lara Santos
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-06-18       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.